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INTRODUCTION
Multifocal inflammatory leukoencephalopathy (MIL) is a
rare syndrome associated with 5-fluorouracil (5-FU) and lev-
amisole chemotherapy (1-6). The radiographic and clinical
features of this syndrome often pose difficulties in distinguish-
ing it from other diseases, especially multiple brain metastases.
We herein describe a patient with MIL related to oral tega-
fur (derivative of 5-FU) and levamisole therapy using thalli-
um-201 (201Tl) single photon emission computed tomography
single photon emission computed tomography (SPECT) and
proton magnetic resonance spectroscopy (MRS) as adjunctive
noninvasive tools in the diagnosis of this reversible syndrome.
CASE REPORT
A 45-yr-old man was admitted to our department with a
gradual onset of right hemiparesis, left facial and arm pares-
thesias, and hiccups. Five months before admission, he had
underwent primary resection of adenocarcinoma of the rec-
tum. Two months after the operation, he received adjuvant
chemotherapy with tegafur ([1-(2-tetrahydrofuryl)-5-FU],
600 mg/day orally) and levamisole (100 mg/day orally for
three days, each week) for moderately differentiated stage II
adenocarcinoma. One month before admission, he developed
paresthesia in the left face and arm, and complained of inter-
mittent hiccups. One week later, he experienced progressive
weakness of right extremities and gait disturbance. On admis-
sion, he was alert with intact cognitive function. Neurologic
examination showed decreased left facial and arm sensation,
mild right hemiparesis, moderately increased deep tendon
reflexes, and clumsiness of right side on gait. He was afebrile
throughout the illness.
Brain MRI revealed multiple, ring- or nodular-enhancing
white matter lesions, scattered throughout the cerebral hemi-
spheres and two separate non-enhancing brainstem lesions in-
volving the left middle cerebellar peduncle and dorsolateral
medulla oblongata (Fig. 1). Cerebrospinal fluid (CSF) exam-
ination showed a normal opening pressure, pleocytosis (22
cells/ L, 90% of lymphocytes), normal glucose, and increased
protein; cultures for bacterial, fungal, and acid-fast bacilli, and
cytologic findings were negative; ELISA test for parasites and
PCR test for viruses were all negative. Other general labora-
tory tests revealed no abnormalities.
On the fourth day of admission, proton MRS (Simens Vison
Plus 1.5T, PRESS 2D with single voxel) was performed, which
revealed high choline (Cho) and lactate with relative preser-
vatioan of N-acetylaspartate (NAA) (Fig. 2). On the 10th day,
brain 201Tl SPECT showed no abnormal uptake. A stereotac-
tic brain biopsy targeting the ring-enhancing lesion in the left
frontal area was done on the 14th day. 
Histopathology revealed demyelinating lesions in white
matter with relative axonal sparing; perivascular lymphocyt-
ic cuffing, macrophage infiltration, and scattered hyperplas-
tic astrocytes were noted.
With discontinuation of tegafur and levamisole, he began
to receive corticosteroid therapy. Two weeks after discharge, his
neurologic condition improved markedly, as evidenced by
improved extremity weakness and paresthesia. Repeated brain
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Multifocal Inflammatory Leukoencephalopathy: Use of Thallium-201
SPECT and Proton MRS
In a patient receiving 5-fluorouracil and levamisole, neurologic deficits suggest the
cerebral demyelinating syndrome as a differential diagnosis. The authors report a
patient diagnosed as multifocal inflammatory leukoencephalopathy for which thalli-
um-201 (
201Tl) single photon emission computed tomography (SPECT) and proton
magnetic resonance spectroscopy (MRS) were employed as noninvasive diagnos-
tic tools. 
201Tl SPECT study was negative and proton MRS showed an increase of
choline and lactate and well preserved N-acetylaspartate. These findings support
histopathologic findings of multifocal inflammatory leukoencephalopathy revealing
demyelination with relative axonal sparing in the patient.
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MRI performed two months after discontinuation of this reg-
imen revealed decreased, but persistent, multifocal cerebral
and brainstem T2 hyperintensities; however, none of these
lesions were enhanced.
DISCUSSION
There are several clinical reports of MIL developed in patients
treated with 5-FU and levamisole or levamisole alone (1-6).
The clinical features of this syndrome are subacute progressive
neurologic symptoms and signs including confusion, behav-
ioral change, memory impairment, dysarthria, paresthesia,
hemiparesis, ataxia, and diplopia. All developed within five
months of initiation of therapy (1-6). Brain MRI revealed mul-
tiple enhancing white matter lesions with predilection for the
periventricular areas (1-6). CSF studies revealed mild pleocy-
tosis, increased protein, and sometimes the presence of an oligo-
clonal band, increased IgG index, or elevated TNF- level (1,
2).All patients improved once 5-FU and levamisole were dis-
continued (1-6).A beneficial response to short-term treatment
with corticosteroids was also observed. Repeated imaging stud-
ies demonstrated loss of lesion enhancement and decreased size
of lesions (3-5). Stereotactic brain biopsy revealed an inflam-
matory demyelinating lesion with relative axonal sparing (1-
3, 6).
Both levamisole and 5-FU have been implicated in the eti-
ology of this syndrome. However, the pathogenesis of this syn-
drome has not been clarified. In normal mice, levamisole and
5-FU are not directly toxic to myelin (7). When these agents
are administered to mice infected with a demyelination-induc-
ing virus, however, demyelination and inflammation are aug-
mented and accelerated (7). Thus, treatment with levamisole
and 5-FU may enhance a pathologic immune response toward
a persistent antigen capable of producing demyelinating dis-
ease in a susceptible host (7).
Among 1,030 patients treated with levamisole alone or lev-
amisole and 5-FU as a surgical adjuvant therapy for colon can-
cer, neurologic symptoms or signs developed in 3.1% of all
cases during treatment and in 4.5% of patients treated with
Fig. 1. Brain MRI with gadolinium enhancement. (A, B) T2-weighted images and T1-weighted images after gadolinium administration at the
time of presentation. (C, D) T2-weighted images and T1-weighted images after gadolinium administration at follow-up after corticosteroid
therapy, which show markedly resolving subcortical enhancing lesions.
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Fig. 2. Proton MRS shows increased choline and lactate with rel-
atively normal N-acetylaspartate consistent with demyelination.
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levamisole and 5-FU (2). However, there are few case reports
on MIL related to this regimen (1-6). With above findings, it
may be assumed that physicians might have misdiagnosed the
disease as other diseases, especially multiple brain metastases.
There was one patient with MIL who initially was misdiag-
nosed as multiple brain metastases and received radiothera-
py for two weeks (1). Thus, it is important to differentiate
this benign reversible demyelinating syndrome from other
diseases.
The differential diagnosis of patients receiving 5-FU and
levamisole presenting with multiple white matter lesions in-
cludes metastatic intracranial colon carcinoma, brain abscess-
es, multicentric glioma, primary central nervous system lym-
phoma, toxoplasmosis, and progressive multifocal leukoen-
cephalopathy (PML). In our patient, immunocompetent state,
negative CSF ELISA test for toxoplasmosis, and no viral inclu-
sions in brain biopsy make the diagnosis of toxoplasmosis or
PML unlikely. The discrimination between MIL and multi-
ple brain metastases is difficult problem in clinical and lab-
oratory backgrounds.
201Tl SPECT is a noninvasive method which may help to
differentiate intracranial tumors from other non-neoplastic
diseases (8). Uptake of 201Tl into tumor cells may be related
to multiple factors, including regional blood flow, blood-brain
barrier permeability, and cellular uptake. The sensitivity of
201Tl SPECT for supratentorial tumors in general was 71.7%
and specificity was 80.9% in one study (8). In their subgroup
of 14 patients with brain metastases, only one patient with
pontine metastasis was negative on the scan (8). One patient
who showed multiple enhancing white matter lesions in MRI
and in whom brain metastasis was suspicious was diagnosed
as MIL aided with negative 201Tl SPECT and active demyelina-
tion revealed by histopathologic examination (3). 201Tl SPECT
was also negative in our patient. Based on this previous case
and our experience, we could speculate that negative 201Tl
SPECT may be helpful in the diagnosis of MIL in patients
receiving 5-FU and levamisole.
Accurate histologic diagnosis is most important, especial-
ly when atypical pattern of malignancy is suspected. It may
change the treatment plan or clinical outcome in such cases
when supported by stereotactic or open brain biopsy. However,
these procedures have significant limitations or risks, such as
inadequate specimens, lesions of high surgical risks, or sur-
gical or anesthetic complications. Proton MRS provides more
information in tissue characterization and may be helpful in
differential diagnosis of intracranial mass lesions. In 15 patients
with suspicious primary brain tumors, proton MRS was used
to compare histopathology with MRS interpretation (9). MRS
accurately predicted the pathological nature and clinical out-
come of lesions in 15/16 (96%) situations, and influenced clin-
ical decision making in 12 cases, and altered surgery planning
in seven patients (9).In three young patients with suspicious
multiple sclerosis, MRS-detected decrease of NAA was cor-
related with a relative decrease of axonal density in immuno-
pathology of corresponding biopsy specimens (10). Concomi-
tant increases of Cho and myo-inositol corresponded to glial
proliferation, and elevated lactate levels were associated with
inflammation (10). In our patient, proton MRS revealed incr-
eased Cho and lactate, which reflected demyelination and
inflammation processes with macrophage activation consid-
ering histopathologic findings. The NAA, as an indicator of
neuroaxonal integrity, was not decreased, which explains excel-
lent clinical recovery after discontinuation of the regimen and
well-preserved axons on histopathology.
As far as we know, our patient is the first case of MIL in
which MRS findings consistent with histopathology of MIL
were demonstrated. We performed stereotactic brain biopsy
for the confirmatory diagnosis; however, the results of MRS
and SPECT in our patient may offer valuable information on
the management of MIL in the future. In colorectal cancer pa-
tients receiving 5-FU and levamisole or levamisole alone devel-
op focal neurologic deficit, if brain MR imaging or CT shows
multifocal enhancing lesions, we recommend proton MRS,
brain 201Tl SPECT, or both as noninvasive diagnostic tools to
exclude brain metastasis before stereotactic brain biopsy.
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